Aytu BioPharma Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement SAMG Q1 2026 Earnings EPS Misses by 364 as Revenue Details Remain Undisclosed FCPT Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher VTAK Q1 2025 Earnings Significant EPS Miss Amidst Operational Challenges STEX Q1 2026 Earnings Major EPS Miss but Stock Surges on Optimism MXCT Q1 2026 Earnings EPS Surprise Beats Estimates by 51 Shares Rally 8